These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 20509346)
1. UK interventions to control medicines wastage: a critical review. White KG Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346 [TBL] [Abstract][Full Text] [Related]
2. Do generics offer significant savings to the UK National Health Service? Kanavos P Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472 [TBL] [Abstract][Full Text] [Related]
3. Generic drug utilisation on the General Medical Services (GMS) scheme in 2001. Tilson L; McGowan B; Ryan M; Barry M Ir Med J; 2003 Jun; 96(6):176-9. PubMed ID: 12926759 [TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care. Counterweight Project Team J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765 [TBL] [Abstract][Full Text] [Related]
5. Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK. Doble B; Payne R; Harshfield A; Wilson ECF BMJ Open; 2017 Dec; 7(12):e019382. PubMed ID: 29208621 [TBL] [Abstract][Full Text] [Related]
6. Potential savings from generic prescribing and generic substitution in South Africa. Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460 [TBL] [Abstract][Full Text] [Related]
7. Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data. Goldacre B; Reynolds C; Powell-Smith A; Walker AJ; Yates TA; Croker R; Smeeth L BMJ Open; 2019 Feb; 9(2):e026886. PubMed ID: 30813120 [TBL] [Abstract][Full Text] [Related]
8. Projecting expenditure on medicines in the UK NHS. O'Neill P; Mestre-Ferrandiz J; Puig-Peiro R; Sussex J Pharmacoeconomics; 2013 Oct; 31(10):933-57. PubMed ID: 24037786 [TBL] [Abstract][Full Text] [Related]
9. New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study. Croker R; Walker AJ; Bacon S; Curtis HJ; French L; Goldacre B BMJ Open; 2018 Feb; 8(2):e019643. PubMed ID: 29439078 [TBL] [Abstract][Full Text] [Related]
10. Influence of prescription charges on repeat prescribing in primary care. Bradley F; Elvey R; Ashcroft DM; Noyce P J Clin Pharm Ther; 2007 Jun; 32(3):269-75. PubMed ID: 17489879 [TBL] [Abstract][Full Text] [Related]
11. Individualisation or standardisation: trends in National Health Service prescription durations in England 1998-2009. Davies JE; Taylor DG Prim Health Care Res Dev; 2013 Apr; 14(2):164-74. PubMed ID: 23031628 [TBL] [Abstract][Full Text] [Related]
12. Effect of fundholding and indicative prescribing schemes on general practitioners' prescribing costs. Bradlow J; Coulter A BMJ; 1993 Nov; 307(6913):1186-9. PubMed ID: 8251847 [TBL] [Abstract][Full Text] [Related]
13. A probabilistic cost-effectiveness analysis of escitalopram, generic citalopram and venlafaxine as a first-line treatment of major depressive disorder in the UK. Wade AG; Toumi I; Hemels ME Curr Med Res Opin; 2005 Apr; 21(4):631-42. PubMed ID: 15899113 [TBL] [Abstract][Full Text] [Related]
14. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Guest JF; Clegg JP; Smith AF Curr Med Res Opin; 2006 Sep; 22(9):1777-85. PubMed ID: 16968581 [TBL] [Abstract][Full Text] [Related]
15. Does a system of instalment dispensing for newly prescribed medicines save NHS costs? Results from a feasibility study. Millar J; McNamee P; Heaney D; Selvaraj S; Bond C; Lindsay S; Morton M Fam Pract; 2009 Apr; 26(2):163-8. PubMed ID: 19126830 [TBL] [Abstract][Full Text] [Related]
16. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital. Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off. Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667 [TBL] [Abstract][Full Text] [Related]
18. The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge. Silcock J; Ryan M; Bond CM; Taylor RJ Pharmacoeconomics; 1997 Jan; 11(1):56-63. PubMed ID: 10165527 [TBL] [Abstract][Full Text] [Related]
19. Long-Term Costs and Health Consequences of Issuing Shorter Duration Prescriptions for Patients with Chronic Health Conditions in the English NHS. Martin A; Payne R; Wilson EC Appl Health Econ Health Policy; 2018 Jun; 16(3):317-330. PubMed ID: 29532329 [TBL] [Abstract][Full Text] [Related]
20. Medicaid prescription limits: policy trends and comparative impact on utilization. Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]